144 related articles for article (PubMed ID: 12849923)
1. Study on lifestyle-intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results.
Mensink M; Corpeleijn E; Feskens EJ; Kruijshoop M; Saris WH; de Bruin TW; Blaak EE
Diabetes Res Clin Pract; 2003 Jul; 61(1):49-58. PubMed ID: 12849923
[TBL] [Abstract][Full Text] [Related]
2. Subscapular skinfold thickness distinguishes between transient and persistent impaired glucose tolerance: Study on Lifestyle-Intervention and Impaired Glucose Tolerance Maastricht (SLIM).
Mensink M; Feskens EJ; Kruijshoop M; de Bruin TW; Saris WH; Blaak EE
Diabet Med; 2003 Jul; 20(7):552-7. PubMed ID: 12823236
[TBL] [Abstract][Full Text] [Related]
3. Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study.
Corpeleijn E; Feskens EJ; Jansen EH; Mensink M; Saris WH; de Bruin TW; Blaak EE
Diabetologia; 2006 Oct; 49(10):2392-401. PubMed ID: 16896932
[TBL] [Abstract][Full Text] [Related]
4. Predictors of lifestyle intervention outcome and dropout: the SLIM study.
Roumen C; Feskens EJ; Corpeleijn E; Mensink M; Saris WH; Blaak EE
Eur J Clin Nutr; 2011 Oct; 65(10):1141-7. PubMed ID: 21587283
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of type II diabetes mellitus in population of Krakow].
Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
[TBL] [Abstract][Full Text] [Related]
6. Study on Lifestyle Intervention and Impaired Glucose Tolerance Maastricht (SLIM): preliminary results after one year.
Mensink M; Feskens EJ; Saris WH; De Bruin TW; Blaak EE
Int J Obes Relat Metab Disord; 2003 Mar; 27(3):377-84. PubMed ID: 12629566
[TBL] [Abstract][Full Text] [Related]
7. Prevention of the metabolic syndrome in IGT subjects in a lifestyle intervention: results from the SLIM study.
den Boer AT; Herraets IJ; Stegen J; Roumen C; Corpeleijn E; Schaper NC; Feskens E; Blaak EE
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1147-53. PubMed ID: 23462149
[TBL] [Abstract][Full Text] [Related]
8. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.
Franciosi M; De Berardis G; Rossi MC; Sacco M; Belfiglio M; Pellegrini F; Tognoni G; Valentini M; Nicolucci A
Diabetes Care; 2005 May; 28(5):1187-94. PubMed ID: 15855587
[TBL] [Abstract][Full Text] [Related]
9. A screening procedure detecting high-yield candidates for OGTT. The Women's Health in the Lund Area (WHILA) study: a population based study of middle-aged Swedish women.
Lidfeldt J; Nerbrand C; Samsioe G; Scherstén B; Agardh CD
Eur J Epidemiol; 2001; 17(10):943-51. PubMed ID: 12188015
[TBL] [Abstract][Full Text] [Related]
10. Lifestyle intervention and adipokine levels in subjects at high risk for type 2 diabetes: the Study on Lifestyle intervention and Impaired glucose tolerance Maastricht (SLIM).
Corpeleijn E; Feskens EJ; Jansen EH; Mensink M; Saris WH; Blaak EE
Diabetes Care; 2007 Dec; 30(12):3125-7. PubMed ID: 17890316
[TBL] [Abstract][Full Text] [Related]
11. [Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow].
Szurkowska M; Szafraniec K; Gilis-Januszewska A; Pach D; Krzentowska A; Szybiński Z; Huszno B
Przegl Lek; 2006; 63(9):728-32. PubMed ID: 17479858
[TBL] [Abstract][Full Text] [Related]
12. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.
Kosaka K; Noda M; Kuzuya T
Diabetes Res Clin Pract; 2005 Feb; 67(2):152-62. PubMed ID: 15649575
[TBL] [Abstract][Full Text] [Related]
13. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.
Hanefeld M; Koehler C; Fuecker K; Henkel E; Schaper F; Temelkova-Kurktschiev T;
Diabetes Care; 2003 Mar; 26(3):868-74. PubMed ID: 12610051
[TBL] [Abstract][Full Text] [Related]
14. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.
Unwin N; Shaw J; Zimmet P; Alberti KG
Diabet Med; 2002 Sep; 19(9):708-23. PubMed ID: 12207806
[TBL] [Abstract][Full Text] [Related]
15. Impaired fasting glucose and impaired glucose tolerance in rural population of Bangladesh.
Rahim MA; Azad Khan AK; Nahar Q; Ali SM; Hussain A
Bangladesh Med Res Counc Bull; 2010 Aug; 36(2):47-51. PubMed ID: 21473200
[TBL] [Abstract][Full Text] [Related]
16. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].
Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D
Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591
[TBL] [Abstract][Full Text] [Related]
17. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.
Jensen CC; Cnop M; Hull RL; Fujimoto WY; Kahn SE;
Diabetes; 2002 Jul; 51(7):2170-8. PubMed ID: 12086947
[TBL] [Abstract][Full Text] [Related]
18. Effects of exercise training alone vs a combined exercise and nutritional lifestyle intervention on glucose homeostasis in prediabetic individuals: a randomised controlled trial.
Slentz CA; Bateman LA; Willis LH; Granville EO; Piner LW; Samsa GP; Setji TL; Muehlbauer MJ; Huffman KM; Bales CW; Kraus WE
Diabetologia; 2016 Oct; 59(10):2088-98. PubMed ID: 27421729
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of steroid-induced glucose intolerance with normal fasting glycaemia during low-dose glucocorticoid therapy: an oral glucose tolerance test screening study.
Nowak KM; Rdzanek-Pikus M; Romanowska-Próchnicka K; Nowakowska-Płaza A; Papierska L
Rheumatology (Oxford); 2021 Jun; 60(6):2842-2851. PubMed ID: 33254223
[TBL] [Abstract][Full Text] [Related]
20. People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.
Amini M; Horri N; Zare M; Haghighi S; Hosseini SM; Aminorroaya A; Hovsepian S
Ann Nutr Metab; 2010; 56(4):267-72. PubMed ID: 20413967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
